Turtle Beach Corporation, Together With The Donerail Group, Announces $20 Million Share Repurchase From Shareholder
Globenewswire· 2025-08-15 13:00
SAN DIEGO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Turtle Beach Corporation (Nasdaq: TBCH, the “Company”), a leading gaming accessories brand, today announced it entered into a definitive agreement to repurchase 694,926 shares of common stock from Diversis Capital (“Diversis”), at the 30-day volume weighted average price of $14.41 per share, for a total of approximately $10 million. Simultaneous with the Company’s repurchase, The Donerail Group (“Donerail”), an investment management firm, has acquired 693,962 sh ...
AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Globenewswire· 2025-08-15 13:00
Continued progress across pipeline programs with focus on pancreatic cancer Mid-year report of Ampligen® (rintatolimod) in combination with AstraZeneca’s Imfinzi® (durvalumab) for the treatment of pancreatic cancer demonstrates promising signs of both no significant toxicity and superior PFS and OS Bolstered cash position provides runway to fund operations for approximately 12 months OCALA, Fla., Aug. 15, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today report ...
Opendoor Announces CEO Search in Support of Next Phase of Growth and Innovation
Globenewswire· 2025-08-15 13:00
Shrisha Radhakrishna appointed as President and interim leader of OpendoorSAN FRANCISCO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. (Nasdaq: OPEN), a leading e-commerce platform for residential real estate transactions, today announced that effective immediately, the Board has appointed Shrisha Radhakrishna as President and interim leader of Opendoor. Carrie Wheeler, Opendoor’s current Chief Executive Officer and Chair of the Board, has made the decision to step down from her roles with th ...
Avance Gas Holding Ltd: Reminder on appointment of joint liquidators, de-listing of shares and dissolution
Globenewswire· 2025-08-15 13:00
Avance Gas Holding Ltd (the “Company”) reminds shareholders that on 16 May 2025 the shareholders of the Avance Gas Holding Ltd (the “Company”) passed resolutions (the “Resolutions”) that the Company be wound up voluntarily and that Michael Penrose of EY Bermuda Ltd., 3 Bermudiana Road, Hamilton, HM08, Bermuda and Igal Wizman of EY Bahamas Ltd., Caves Corporate Centre, West Bay Street & Blake Road, Nassau N-3231, The Bahamas, be appointed as Joint Liquidators (“JLs”) of the Company. The appointment of the JL ...
Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market
Globenewswire· 2025-08-15 13:00
SAN DIEGO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC ID: RGBP and RGBPP) today provided further insight into its planned Phase 1 clinical trial of HemaXellerate, the company’s innovative stem cell-derived therapy, which has already received U.S. FDA clearance. While the initial focus is on treating aplastic anemia, a rare orphan indication, Regen BioPharma is evaluating expanded applications for this groundbreaking therapy in markets poised for significant growth. Regen sees substantial p ...
Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Globenewswire· 2025-08-15 13:00
– Live video webcast on Thursday, August 21st at 2:20 PM ET THE WOODLANDS, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025. Details for the presentation are as follows: Date and Time: Thursday, August 21, 2025 at 2:2 ...
Faraday Future Reminds the Public That it Will Announce a Major Strategy Upgrade With its Dual-Flywheel & Dual-Bridge Eco Strategy on August 16th, at Pebble Beach
Globenewswire· 2025-08-15 13:00
Core Viewpoint - Faraday Future is set to announce a major strategic upgrade, the Dual-Flywheel & Dual-Bridge Eco Strategy, on August 16 at Pebble Beach, marking a significant milestone in the company's evolution and potential growth opportunities [5][8][9]. Group 1: Announcement Details - The announcement will take place on August 16, 2025, at 7:30 PM PDT during the Monterey Car Week [15]. - The event will include a company update and showcase vehicles such as the FF 91 2.0 and FX Super One [15]. - A 5-day countdown leading to the announcement has been completed, with teasers highlighting specific components of the new strategy [9][11]. Group 2: Strategic Components - The Dual-Flywheel & Dual-Bridge Eco Strategy aims to create a cross-sector ecosystem that enhances integration and generates new value, resulting in outcomes where 1 + 1 > 2 [12]. - The Flywheel Effect is a management framework that builds a self-reinforcing loop through key actions, enhancing product capabilities and operational efficiency [13]. - The FF Bridge Strategy, launched in May 2024, focuses on leveraging global supply chain strengths and innovation in the U.S. to unlock opportunities in the AIEV market [14]. Group 3: Company Background - Faraday Future is a California-based company focused on creating a shared intelligent electric mobility ecosystem, aiming to disrupt the automotive industry with a user-centric and technology-first approach [20]. - The flagship model, FF 91, represents the company's vision for luxury and innovation, while the FX strategy targets mass production models at a lower price point [20].
Cingulate Provides Management Team Update
Globenewswire· 2025-08-15 13:00
Group 1 - Cingulate Inc. has placed its Chairman and CEO, Shane J. Schaffer, on administrative leave due to ongoing legal matters unrelated to the company [2] - Jennifer Callahan, the Chief Financial Officer, has been appointed as the interim CEO to ensure business continuity while retaining her CFO responsibilities [2][4] - Jay Roberts, a board member, has been appointed as Executive Chairman, bringing extensive operational expertise to support the management team [2][3] Group 2 - Cingulate remains committed to its mission of bringing CTx-1301 to patients with ADHD, having submitted a new drug application to the FDA in July [3] - The leadership team has the full confidence of the Board to guide the company forward, emphasizing a commitment to science, innovation, and shareholder value [3] - The executive team supporting Ms. Callahan includes experienced professionals in the ADHD category, such as Dr. Matt Brams, Dr. Raul Silva, and Nilay Patel [5] Group 3 - Cingulate Inc. is a biopharmaceutical company focused on developing next-generation pharmaceutical products using its proprietary PTR drug delivery platform technology [6] - The company aims to improve treatment outcomes for patients with conditions requiring burdensome daily dosing regimens, initially focusing on ADHD and exploring additional therapeutic areas like anxiety disorders [6]
HeartSciences Announces Conference Participation and Investor Webinar
Globenewswire· 2025-08-15 13:00
Core Viewpoint - HeartSciences Inc. is actively engaging with investors through multiple virtual events in August 2025 to showcase its AI-powered ECG technology aimed at early heart disease detection [1][2][3] Group 1: Upcoming Events - The company will host an Investor Webinar on August 20, 2025, at 2:00 PM Eastern Time, providing an overview of its mission, market opportunity, and recent progress [2] - HeartSciences will also present at the Emerging Growth Conference 85 on the same day at 3:10 PM Eastern Time, allowing real-time interaction with investors [3] - Archived webcasts of these events will be available for those unable to attend live [4] Group 2: Company Overview - HeartSciences focuses on enhancing the clinical utility of ECGs through innovative AI technology, aiming to improve cardiac screening, especially in frontline clinical settings [5] - The company possesses one of the largest libraries of AI-ECG algorithms and plans to offer these through a cloud-based solution and a low-cost ECG hardware platform [5] - The MyoVista® wavECG™, the company's first product candidate for FDA clearance, is designed to provide diagnostic information related to cardiac dysfunction alongside conventional ECG data [5]
SAGTEC to Drive Cutting-Edge F&B Technology Transformation for Malaya Heritage
Globenewswire· 2025-08-15 13:00
Group 1: Company Overview - Malaya Heritage Holding Limited is the holding company for CNS Food Centre Sdn Bhd, focusing on preserving cultural authenticity while delivering premium service and quality dining experiences [6] - The company operates multiple heritage-inspired F&B brands in Malaysia, including Kafei Dian, Melaya Nyonya House, and Makan Kaw Kaw [6] - SAGTEC Global Limited specializes in innovative IT solutions for the F&B and hospitality industries, offering expertise in robotics, automation, and smart analytics [4][7] Group 2: Digital Transformation Initiative - Malaya Heritage Holding Limited has appointed SAGTEC Global Limited as its exclusive IT Consultant to lead a comprehensive 24-month digital transformation program across its F&B operations [1] - The partnership will introduce advanced technologies such as automated central kitchen systems, intelligent outlet management platforms, and service robotics to enhance operational efficiency and customer experience [2] - The initiative is projected to generate approximately USD 3 million in revenue, highlighting the commercial potential of technology integration in Malaysia's F&B sector [3] Group 3: Future Plans and Goals - The mission of the digital transformation program is to future-proof Malaya Heritage's operations through innovative, reliable, and scalable technology solutions [5] - SAGTEC and Malaya Heritage plan to explore opportunities in sustainable food technology, predictive analytics, and advanced customer engagement platforms to support long-term growth and industry leadership [5]